https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Health and Social Characteristics of Clients Reporting Amphetamine Type Substance Use at Entry to Public Alcohol and Other Drug Services in New South Wales, Australia, 2016–2019 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50489 Wed 28 Feb 2024 15:28:31 AEDT ]]> Harnessing advances in computer simulation to inform policy and planning to reduce alcohol-related harms https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48957 Wed 19 Apr 2023 08:15:45 AEST ]]> Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:38219 Wed 18 Aug 2021 09:45:21 AEST ]]> Most common principal diagnoses assigned to Australian emergency department presentations involving alcohol use: a multi-centre study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52467 Wed 11 Oct 2023 20:44:39 AEDT ]]> Participant experiences in a pilot study for methamphetamine withdrawal treatment: Implications for retention https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:55236 Wed 01 May 2024 15:39:47 AEST ]]> Lisdexamfetamine for the treatment of acute methamphetamine withdrawal: A pilot feasibility and safety trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52634 Thu 19 Oct 2023 15:11:40 AEDT ]]> Investigating associations between methamphetamine use, mental health and risky sexual behaviours amongst Aboriginal and Torres Strait Islander peoples https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:50902 weekly) (aOR: 2.10, 95% CI: 1.13, 3.90, and 2.73, 95% CI: 1.52, 4.93 for males and females respectively). Among other drugs, using ecstasy was also significantly associated with HSRSB in both genders (aOR: 3.97, 95% CI: 1.17, 13.42 and aOR: 5.32, 95% CI: 2.05, 13.82 for males and females). The combined impact of mental health conditions was substantially higher among females than males (PAR%: 46% and 27%, respectively). The findings may inform the targeting of health promotion programs for STI prevention towards those at higher risk due to methamphetamine use and mental health issues.]]> Thu 10 Aug 2023 13:24:37 AEST ]]> Substance use, socio-demographic characteristics, and self-rated health of people seeking alcohol and other drug treatment in New South Wales: baseline findings from a cohort study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51584 Mon 11 Sep 2023 14:36:30 AEST ]]> A systems change intervention for nurse-led smoking cessation care in hospitals https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:45490 Fri 28 Oct 2022 15:46:27 AEDT ]]> Survey methods and characteristics of a sample of Aboriginal and Torres Strait Islander and non-Indigenous people who have recently used methamphetamine: the NIMAC survey https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:39331 Fri 19 Apr 2024 11:23:25 AEST ]]> Safety and tolerability of oral lisdexamfetamine in adults with methamphetamine dependence: a phase-2 dose-escalation study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47241 Fri 16 Dec 2022 12:15:44 AEDT ]]>